GN Store Nord AS's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 141.27.
GN Store Nord AS's Days Inventory for the
three
months ended in Mar. 2026 was 163.85.
GN Store Nord AS's Days Payable for the
three
months ended in Mar. 2026 was 106.24.
Therefore, GN Store Nord AS's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 198.88.
GN Store Nord AS (OTCPK:GGNDF) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
GN Store Nord AS Cash Conversion Cycle Related Terms
GN Store Nord AS Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for GN Store Nord AS's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GGNDF vs ABT, SYK, MDT: Cash Conversion Cycle Comparison
For the Medical Devices subindustry, GN Store Nord AS's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GN Store Nord AS Cash Conversion Cycle vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GN Store Nord AS's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where GN Store Nord AS's Cash Conversion Cycle falls into.
GN Store Nord AS Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
GN Store Nord AS's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GN Store Nord AS (GGNDF) has a Cash Conversion Cycle of 198.88 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on GN Store Nord AS and its competitors.
Is GN Store Nord AS's Cash Conversion Cycle too high?
GN Store Nord AS's current Cash Conversion Cycle is 198.88. The Medical Devices & Instruments industry median Cash Conversion Cycle is 156.96. GN Store Nord AS's value of 198.88 is 26.7% above this industry median. Overall, GN Store Nord AS has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GN Store Nord AS's Cash Conversion Cycle compare to ABT and SYK?
GN Store Nord AS's Cash Conversion Cycle of 198.88 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash Conversion Cycle is 156.96. GN Store Nord AS's value of 198.88 is 26.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Devices & Instruments company?
The median Cash Conversion Cycle among Medical Devices & Instruments companies is 156.96, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GN Store Nord AS's current Cash Conversion Cycle of 198.88 is 26.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on GN Store Nord AS and its competitors. For the Medical Devices & Instruments industry, the median Cash Conversion Cycle is 156.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GN Store Nord AS's current Cash Conversion Cycle is 198.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GN Store Nord AS stock overvalued right now?
Based on GuruFocus' analysis, GN Store Nord AS (GGNDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $15.78, compared to a current price of $13.63 — trading 13.7% below its estimated fair value. The current Cash Conversion Cycle is 198.88 and 26.7% above the Medical Devices & Instruments industry median of 156.96. GN Store Nord AS's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For GN Store Nord AS (GGNDF), the current Cash Conversion Cycle is 198.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GN Store Nord AS (GGNDF) Overvalued in 2026?
Based on GuruFocus' analysis, GN Store Nord AS stock appears to be undervalued.
The current stock price of $13.63 is trading 13.7% below its estimated GF Value™ of $15.78.
GuruFocus considers GN Store Nord AS to be Modestly Undervalued.
Key valuation signals for GGNDF:
Cash Conversion Cycle: 198.88
GF Value™: $15.78 vs. price of $13.63 (13.7% below fair value)
Industry Position: 26.7% above the Medical Devices & Instruments median
No single metric tells the full story. See the GGNDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GN Store Nord is a Danish company offering medical and audio solutions. The group comprises three businesses: hearing (about 40% of sales), enterprise (40%), and gaming (20%). GN Hearing offers hearing aids and competes globally with Sonova, Demant, Starkey, and WS Audiology (formerly Sivantos and Widex). GN Enterprise provides headsets and speakerphones to the enterprise market, including contact centers and offices. GN recently acquired SteelSeries, a provider of gaming accessories such as headsets and keyboards, thereby forming the gaming division. The company has positioned itself as a major player in the Unified Communication-enabled headsets market. The firm's premium brands are Resound in hearing, Jabra in headsets, and SteelSeries in gaming.
72GF Score
Get the complete analysis for GGNDF
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GGNDF has been successfully added to your 
